SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-026291
Filing Date
2016-08-04
Accepted
2016-08-04 15:30:16
Documents
1
Period of Report
2016-08-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7465
  Complete submission text file 0000899243-16-026291.txt   9626
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Issuer) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address LIKHACHEVSKY DRIVE 5 "B" DOLGOPRUDNY 1Z 141701
Business Address LIKHACHEVSKY DRIVE 5 "B" DOLGOPRUDNY 1Z 141701 7 495 970 0032
Public Joint Stock Co Pharmstandard (Reporting) CIK: 0001598754 (see all company filings)

State of Incorp.: 1Z | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35443 | Film No.: 161807110

Mailing Address 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE LUXEMBOURG N4 L-1528
Business Address 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE LUXEMBOURG N4 L-1528 352 26449 557
Pharmstandard International S.A. (Reporting) CIK: 0001598762 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35443 | Film No.: 161807111